Matthew Oberley, MD, PhD

Matthew Oberley, MD, PhD

Pathology in Phoenix, AZ


Contact


Hide Show

About Dr. Oberley


Dr. Matthew Oberley, MD is a board certified pathologist in Hollywood, California. He is currently licensed to practice medicine in California and Wisconsin. He is affiliated with Children's Hospital Los Angeles.

Hide Show

Services Offered



Hematopathology
MRD evaluation by flow cytometry

Qualifications and Experience



Hide Show

Education & Training

University of Wisconsin Medical School
Fellowship, 2013 - 2014

University of Wisconsin
Residency, Anatomic and Clinical Pathology, 2009 - 2013

University of Wisconsin
Class of 2009

McArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Health
PhD, Oncology, 2000 - 2003

University of Wisconsin
Ph.D., Molecular Toxicology, 2003

University of Colorado
B.A., Biology, 1995

University of Colorado-Boulder
BA, Environmental, Population, and Organismic Biology, 1991 - 1995

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Certifications

American Board of Pathology
Pathology - Anatomic/Pathology - Clinical

American Board of Pathology
Pathology - Hematology

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Medical Licenses

AZ State Medical License
2020 - 2021

CA State Medical License
2015 - 2022

WI State Medical License
2011 - 2021

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Hospital Affiliations

Children's Hospital Los Angeles
Current Affiliation
Los Angeles, CA

University of Southern California
Former Affiliation
Los Angeles, CA

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Awards

Young Investigator Mentee
Children's Oncology Group, 2016

Resident/Fellow Presentation Award
Michael N. Hart Research Day, 2013

Ruth L. Kirschstein National Research Service Award
National Cancer Institute postdoctoral fellowship, 2003, 2004

National Research Service Award predoctoral traineeship from the National Institute for Health Sciences
2001, 2002, 2003

Ruth L. Kirschstein National Research Service Award
National Cancer Institute (NCI), 2003

National Research Service Award
National Institutes of Health (NIH), 2001

NIH Predoctoral Training Grant Award
1998, 1999, 2000

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Publications



PubMed

Bilateral retinal detachment after chimeric antigen receptor T-cell therapy.
Blood advances
Denton, C. C., Gange, W. S., Abdel-Azim, H., Jodele, S., Kapoor, N., Oberley, M. J., Wong, K., Kim, J., Vercio, A., Moghaddampour, P., Chalam, K. V., Sierpina, D., Gardner, R. A., Pulsipher, M. A., Jensen, M. C., Nagiel, A.
5/20/2020

Integrin α6 mediates the drug resistance of acute lymphoblastic B-cell leukemia.
Blood
Gang, E. J., Kim, H. N., Hsieh, Y., Ruan, Y., Ogana, H. A., Lee, S., Pham, J., Geng, H., Park, E., Klemm, L., Willman, C. L., Carroll, W. L., Mittelman, S. D., Orgel, E., Oberley, M. J., Parekh, C., Abdel-Azim, H., Bhojwani, D., Wayne, A. S., De Arcangelis, A., Georges-Labouesse, E., Wayner, E., Bonig, H., Minasyan, A., Hoeve, J. T., Graeber, T. G., Müschen, M., Heisterkamp, N., Kim, Y.
3/29/2020

Significance of minimal residual disease in pediatric mixed phenotype acute leukemia: a multicenter cohort study.
Leukemia
Oberley, M. J., Raikar, S. S., Wertheim, G. B., Malvar, J., Sposto, R., Rabin, K. R., Punia, J. N., Seif, A. E., Cahen, V. C., Schore, R. J., Luca, D. C., Guinipero, T., Woods, W. G., O'Gorman, M. R., Orgel, E.
2/16/2020

See All

Journal Article

Vav1 in hematologic neoplasms, a mini review
American Journal of Blood Research
Oberley MJ, Wang D, and Yang D
1/1/2012

Lecture

Large B-Cell Lymphomas in Pediatric and Young Adults Display Clinically Relevant Molecular Features Distinguishable from Adult Counterparts
12/1/2018
2018 ASH Annual Meeting - San Diego, CA

Predictive Value of Minimal Residual Disease in WHO2016-Defined Mixed Phenotype Acute Leukemia
1/23/2017
University of Wisconsin-Madison

Clinical Significance of Isolated Myeloperoxidase Expression in B Lymphoblastic Leukemia.
1/16/2016
Atlanta, GA

Abstract

Predictive Value of Minimal Residual Disease in WHO2016­Defined Mixed Phenotype Acute Leukemia (MPAL).
ASH 58th Annual Meeting
Orgel E, Oberley MJ, Li S, Malvar J, and O'Gorman MRG
1/1/2016
San Diego, CA

Identification of Novel and Recurrent Copy Number Alterations in Pediatric High Grade B-cell Lymphoma by Chromosomal Microarray.
USC Depatment of Pathology Research Retreat
Hagiya A, Raca G, and Oberley MJ
1/1/2016
Long Beach, CA

A comprehensive gene panel for precise diagnosis and treatment of childhood cancer.
AACR
Triche TJ, Biegel J, Judkins A, Busse T, Wayne A, Bhojwani D, Asgharzadeh S, Oberley MJ, Parham D
1/1/2016
New Orleans, LA

Book Chapter

Microarrays and Transcription Networks
Oberley MJ, and Farnham PJ
1/1/2006

Promoter and CpG Island Microarrays
Oberley MJ, Kirmizis A, and Farnham PJ
1/1/2006

Methods in Enzymology
Oberley MJ, Tsao J, Yau P, and Farnham PJ
1/1/2004

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄